NU2GGH002514

Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) - The achievement of sustainable control of the HIV pandemic is feasible, as demonstrated by the progress made through the President's Emergency Plan for AIDS Relief (PEPFAR) over the past two decades.

However, reaching the 95-95-95 goals for diagnosis, antiretroviral therapy (ART), and suppression of HIV replication requires laser-focused strategies to rapidly identify new infections and interrupt transmission across all age groups, genders, and vulnerable communities.

The PEPFAR five-year strategy for 2022-2026 aims to accelerate the end of the HIV/AIDS epidemic by focusing on prevention, diagnosis, and treatment and addressing inequalities and stigma while advancing health security and global health equity.

Central to achieving these goals is sustainability, with countries taking full ownership of their HIV programming.

The Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE), consortium, led by the University of California, San Francisco (UCSF), aims to promote sustainable leadership in the political, programmatic, financial, and community realms to achieve sustained impact.

ACCELERATE’s partners are UCSF and UC Berkeley (UCB) in the United States; the University of Nairobi (UON) and the Health and Economic Finance Development Consortium (HEFDC) in Kenya; the Makerere Infectious Diseases Institute (IDI) and the School of Public Health (MAKSPH) in Uganda; Mzumbe University (MU) in Tanzania; the University of Namibia (UNAM) in Namibia; the Universidade Eduardo Mondlane (UEM) in Mozambique; and the African Forum for Research and Education in Health (AFREHEALTH).

The consortium partners with local communities and countries to attain equality for adolescent girls and young women, children, and key populations and leverage local knowledge and expertise to develop effective and inclusive interventions.

ACCELERATE's approach is based on three guiding principles: sustainable, country-led programs; high-quality, data-driven, evidence-informed programs; and health equity, especially for most-at-risk and underserved populations.

The consortium's commitment to these principles ensures respect for local knowledge, expertise, and rights, and accountability measures for local capacity building.

ACCELERATE partners will work with host governments and community organizations to implement these six strategies:

Strategy 1: Develop and implement partnership-building strategies to improve health equity and reduce treatment gaps for AGYW, children and youth, and KPs through targeted TA.

Strategy 2: Strengthen host country capacity to implement policies and programs to ensure sustainable HIV epidemic control and robust health systems.

Strategy 3: Build and strengthen the financial and administrative capacity of local organizations to lead sustainable HIV/AIDS and related developmental assistance programs.

Strategy 4: Build and strengthen project management capacity to develop, implement, and evaluate HIV/AIDS programs.

The ACCELERATE consortium has exceptional technical expertise and works in partnership with country partners that prioritize the support of ministries of health and put local expertise and experience first.

This approach enables ACCELERATE to support the activities outlined in the NOFO in a unique way, accelerating epidemic control, with a focus on sustainable systems strengthening to end the HIV epidemic.

San Francisco Regents Of The University Of California

NOT APPLICABLE

93.067 - Global AIDS

CDC Office of Financial Resources (OFR) [HHS - CDC]

Center for Global Health (CGH) [HHS - CDC]

California United States

State-Wide

Strengthening Regional, National, and Subnational Institutional Capacities to Sustainably Combat HIV/AIDS and Tuberculosis under the President's Emergency Plan for AIDS Relief (PEPFAR) (CDC-RFA-GH-23-0044)

Amendment Since initial award the total obligations have increased 278% from $1,568,957 to $5,935,415.